Accuri Reels in $4M in New Investments

Jul 13, 2009

NEW YORK (GenomeWeb News) – Flow cytometry systems maker Accuri Cytometers has received $4 million in Series D financing from current and new investors, the company said today.

The Ann Arbor, Mich.-based firm said it plans to use the funds support manufacturing and marketing of its C6 Flow Cytometer and the CSampler, which is used to automate the C6.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Main menu